singlestrand
rna
virus
exhibit
except
genet
divers
due
low
fidel
replic
group
constitut
major
sourc
emerg
infect
human
ebola
chikungunya
zika
west
nile
viru
middl
east
respiratori
syndromerel
new
human
rna
virus
discov
serolog
nucleic
acid
amplif
techniqu
domin
viru
diagnost
mani
year
becom
increasingli
unabl
respond
everexpand
rang
pathogen
parallel
substanti
global
burden
longestablish
bloodborn
rna
virus
preval
human
immunodefici
viru
hiv
hepat
c
viru
hcv
infect
million
least
million
peopl
worldwid
develop
countri
blood
transplant
product
routin
screen
virus
howev
even
within
two
rel
wellcharacteris
viru
speci
new
genotyp
divis
recombin
variant
question
rais
regard
reliabl
commerci
assay
detect
new
isol
human
sever
anim
host
includ
pig
hepat
e
viru
hev
cours
last
decad
becom
lead
caus
worldwid
acut
viral
hepat
estim
death
annual
prime
exampl
emerg
zoonosi
signific
blood
safeti
implic
convent
serolog
screen
method
seem
poorli
new
avenu
diagnost
assay
develop
open
advent
next
gener
sequenc
ng
technolog
metagenom
direct
genet
analysi
genom
contain
within
sampl
repres
one
possibl
instead
target
specif
genom
region
predetermin
target
short
dna
sequenc
read
gener
deriv
full
rang
genom
materi
present
number
group
attempt
detect
characteris
rna
virus
clinic
relev
directli
sampl
materi
low
rel
abund
viral
genom
materi
within
clinic
sampl
compar
hostderiv
nucleic
acid
speci
limit
potenti
util
diagnost
virolog
absenc
signific
host
deplet
genom
coverag
depth
often
low
even
high
viral
copi
sever
report
detail
method
partit
viral
host
materi
physicochem
purif
viru
particl
use
variou
combin
filtrat
differenti
centrifug
precipit
extravirion
nucleas
digest
prior
extract
also
suffer
low
viru
read
frequenc
consequ
low
depth
coverag
partial
frequent
altern
method
select
elimin
host
nucleic
acid
specif
ribosom
rna
speci
rrna
constitut
approxim
total
cellular
rna
vidisca
one
approach
viral
nucleic
acid
preferenti
amplifi
use
nonrandom
hexam
complement
human
rrna
sequenc
combin
ng
partial
genom
novel
virus
detect
nondeplet
method
extens
work
need
fulli
characteris
detect
virus
appli
diagnost
virolog
read
depth
genom
coverag
remain
low
even
high
viral
group
select
deplet
rrna
hybridis
rrnaspecif
dna
scissor
probe
extract
nucleic
acid
digest
rrnadna
duplex
rnase
approach
exploit
good
effect
lassa
ebola
extrem
low
amount
rna
surviv
host
deplet
often
picogram
rang
present
signific
challeng
rna
librari
prepar
method
typic
requir
least
ng
start
multipl
displac
amplif
mda
system
success
gener
whole
genom
hiv
low
copi
number
sampl
howev
prepar
dilut
high
titr
clinic
hiv
sampl
pb
impact
high
host
background
gener
mda
display
target
amplif
bias
limit
potenti
metagenom
detect
identif
rather
whole
genom
studi
establish
sequenceindepend
rna
librari
prepar
method
suitabl
detect
character
bloodborn
rna
virus
method
focus
increas
rel
abund
viral
rna
within
sampl
rna
extract
process
specialis
librari
prepar
step
abl
process
ultralow
rna
input
rna
enrich
step
enabl
recoveri
higher
proport
read
viral
origin
constitut
major
advanc
make
viru
genom
assembl
less
challeng
lead
notabl
improv
sequenc
coverag
depth
protocol
test
complex
hostenrich
sampl
contain
hcv
hiv
hev
complet
genom
recov
equival
iuml
mix
viru
panel
compris
differ
human
rna
virus
divers
term
genom
structur
characterist
analys
order
evalu
capabl
protocol
detect
potenti
new
emerg
virus
present
plasma
sampl
appli
method
seri
sampl
taken
hcvinfect
patient
demonstr
util
techniqu
fulli
characteris
strain
hcv
togeth
complet
genom
previous
undetect
human
pegiviru
viru
investig
demonstr
patient
hcv
viru
constitut
new
subtyp
within
genotyp
second
manuscript
detail
clinic
case
prepar
experi
perform
accord
guidanc
conduct
research
public
health
england
version
octob
document
code
studi
involv
use
archiv
residu
sampl
sent
nation
refer
laboratori
routin
diagnosi
sequenc
character
consent
leftov
sampl
use
assay
sampl
anonym
remov
patient
identifi
inform
assign
nonspecif
project
number
prior
genet
character
complex
hostenrich
sampl
prepar
dilut
neg
human
plasma
nhp
neg
hiv
hcv
hev
store
plasma
four
sampl
previous
character
routin
diagnost
test
contain
hcv
hiv
hev
see
tabl
detail
nhp
obtain
centrifug
neg
human
blood
minut
g
remov
cell
debri
final
concentr
viru
primari
panel
sampl
iuml
copiesml
hiv
impli
iu
henceforth
conveni
three
serial
tenfold
dilut
nhp
prepar
stock
reagent
compris
suspens
pb
rna
virus
differ
genom
structur
characterist
provid
nation
institut
biolog
standard
control
nibsc
potter
bar
uk
viral
compon
approxim
rel
concentr
given
mee
et
prior
extract
panel
mix
nhp
duplic
extract
perform
repres
origin
panel
volum
togeth
singl
extract
origin
panel
suspens
four
plasma
sampl
collect
patient
submit
public
health
england
phe
metagenom
analysi
previou
genotyp
result
inconsist
recent
test
employ
report
presenc
viru
belong
genotyp
unabl
resolv
subtyp
precis
extract
sampl
centrifug
min
g
remov
cell
debri
triplic
duplic
singl
extract
perform
dilut
vmr
panel
sampl
refer
vmr
panel
abpb
bbv
panel
sampl
patient
sampl
seri
respect
neg
control
compris
plasma
use
dilut
panel
also
extract
split
rna
extract
kit
lexogen
use
extract
sampl
input
accord
manufactur
instruct
acid
phenol
use
preferenti
recov
larg
rna
fraction
elut
nucleasefre
water
rna
eluat
quantifi
use
qubit
rna
hs
assay
kit
thermo
fisher
scientif
accur
concentr
ribosom
rna
deplet
dna
digest
achiev
use
riboeras
kit
kapa
biosystem
sampl
extract
detect
limit
qubit
quantif
system
total
rna
input
less
recommend
ng
manufactur
specif
follow
except
use
entir
extract
dna
digest
reaction
clean
elut
residu
rna
nucleasefre
water
case
bbv
panel
two
three
extract
dilut
treat
riboeras
kit
rna
librari
prepar
third
set
extract
remain
untreat
use
monitor
effect
rrna
deplet
dna
digest
upon
subsequ
librari
prepar
sequenc
analysi
case
vmr
panel
two
duplic
neg
control
rrna
dna
deplet
perform
extract
case
uncharacter
hcv
strain
extract
four
sampl
treat
riboeras
addit
untreat
extract
sampl
includ
monitor
process
librari
construct
extract
rna
rrnadeplet
dnasedigest
rna
use
nebnext
ultra
direct
rna
librari
prep
kit
new
england
biolab
protocol
design
use
minimum
rna
input
ng
sever
modif
made
adapt
ultralow
rna
input
list
tabl
librari
analys
size
distribut
use
high
sensit
dna
kit
agil
bioanalys
instrument
quantifi
use
kapa
sybr
fast
univers
qpcr
kit
illumina
librari
kapa
biosystem
realtim
pcr
system
appli
biosystem
determin
rel
abund
viral
insert
librari
construct
bbv
panel
analys
qpcr
primer
probe
target
three
viral
compon
ref
supplementari
tabl
reaction
perform
use
quantitect
viru
kit
qiagen
accord
manufactur
instruct
librari
label
differ
index
dilut
nm
pool
sequenc
perform
illumina
miseq
instrument
use
miseq
reagent
kit
cycl
illumina
accord
manufactur
guidelin
follow
minor
modif
librari
pool
denatur
n
sodium
hydroxid
minut
rather
dilut
kit
reagent
produc
pm
solut
dilut
pm
librari
pool
dilut
load
onto
miseq
cartridg
member
multifasta
refer
file
bbv
panel
obtain
submit
fastq
set
rrnadeplet
sampl
highest
viru
concentr
spadeshmmermap
approach
describ
previou
paragraph
vmr
panel
refer
deriv
sequenc
obtain
genbank
use
access
number
mee
et
addit
complet
genom
sequenc
human
pegiviru
hpgv
present
plasma
diluent
discov
spade
contig
file
hmm
profil
construct
align
genbank
sequenc
supplementari
tabl
obtain
fulllength
hcv
genom
fastq
set
submit
spadeshmmermap
process
complet
genom
obtain
hcvmatch
contig
align
fulllength
genom
use
addit
contig
length
kb
align
hmm
profil
submit
identif
follow
analysi
addit
pegiviru
genom
deriv
similar
fashion
hcv
genom
use
hmm
profil
nhp
pegiviru
calcul
read
percentag
coverag
plot
samplederiv
fulllength
genom
sequenc
hcv
hpgv
use
refer
sequenc
map
sampl
correspond
trim
pairedend
fastq
well
incomplet
hcv
genom
obtain
bloodborn
viru
bbv
panel
prepar
compris
two
strain
hcv
genotyp
one
hiv
hev
dilut
nhp
iuml
three
tenfold
serial
dilut
plasma
made
origin
panel
ribosom
rna
deplet
perform
two
set
triplic
extract
prior
three
subject
modifi
librari
prepar
protocol
data
concentr
rrnadeplet
sampl
use
gener
individu
viru
genom
sequenc
use
refer
map
data
analysi
unexpect
human
pegiviru
hpgv
found
trace
nhp
diluent
full
genom
sequenc
hpgv
determin
data
includ
map
refer
tabl
give
read
count
genom
coverag
median
depth
virusdilut
combin
across
three
sampl
per
dilut
test
sampl
yield
read
except
gave
read
except
two
sampl
small
volum
nhp
ad
clinic
sampl
percentag
read
map
hpgv
remain
rel
constant
except
overal
viral
read
percentag
lower
expect
correspond
elev
read
map
human
genom
suggest
possibl
incomplet
dnase
digest
rrna
deplet
step
supplementari
tabl
increas
dilut
total
viral
read
percentag
exclud
hpgv
declin
complet
nearcomplet
genom
coverag
depth
greater
achiev
iuml
four
virus
short
region
hiv
low
coverag
reflect
reduc
overal
viral
read
dataset
minimum
depth
coverag
achiev
sampl
sequenc
pol
coverag
iuml
hcv
hev
continu
give
coverag
median
depth
hcv
hiv
gave
coverag
median
depth
coverag
median
depth
respect
despit
read
map
four
virus
collect
genom
coverag
achiev
median
depth
figur
illustr
coverag
depth
across
target
genom
dilut
show
even
distribut
read
across
four
target
genom
hpgv
pool
duplic
consist
improv
coverag
final
column
tabl
clearli
seen
lower
viral
load
iuml
three
four
virus
achiev
combin
coverag
hiv
iuml
combin
coverag
four
virus
effect
would
expect
individu
coverag
independ
ie
covaub
cova
covb
percentag
read
map
rna
viru
genom
rrnadeplet
bbv
panel
sampl
higher
correspond
untreat
control
individu
target
viru
ratio
decreas
becam
dilut
hcv
hiv
lowest
dilut
concomitantli
ratio
hpgv
rose
markedli
reflect
effect
constant
viral
load
decreas
quantiti
panel
virus
tabl
fig
genom
coverag
median
depth
valu
also
much
higher
treat
sampl
untreat
compar
two
highest
viru
concentr
median
depth
higher
treat
versu
untreat
sampl
short
fragment
hev
recov
untreat
dilut
almost
hiv
hcv
sequenc
contrast
near
complet
genom
four
target
virus
recov
treat
compar
median
depth
note
hiv
except
coverag
median
depth
abil
method
recov
genom
sequenc
rang
rna
virus
context
human
plasma
evalu
use
viru
multiplex
refer
vmr
panel
put
contain
genom
physicochem
divers
virus
two
plasmadilut
panel
one
pbsdilut
panel
test
tabl
read
either
three
sampl
map
either
two
noroviru
genom
coronaviru
influenza
b
viru
panel
distributor
threshold
cycl
ct
coronaviru
three
detect
henc
four
target
exclud
analysi
notwithstand
influenza
viru
parainfluenza
viru
type
also
detect
qpcr
recov
read
genom
coverag
rang
almost
read
belong
panel
dna
virus
found
sixtynin
percent
read
obtain
pbsdilut
panel
map
vmr
panel
genom
drop
plasmadilut
sampl
although
distribut
read
target
uneven
parechoviru
rotaviru
account
viral
read
respect
virus
collect
account
depth
genom
coverag
show
invers
correl
given
cq
valu
fig
bbv
panel
data
coverag
plot
sampl
dilut
plasma
larg
unbias
give
pool
genom
coverag
close
expect
independ
distribut
read
replic
tabl
final
column
rotaviru
coxsackieviru
except
despit
larg
number
map
read
almost
ident
pattern
read
coverag
gap
observ
replic
minim
addit
effect
pbsdilut
sampl
gave
larger
read
number
distribut
less
even
throughout
genom
result
rel
lower
coverag
four
plasma
sampl
patient
hcv
use
start
materi
extract
subject
riboeras
treatment
second
extract
sampl
remain
untreat
comparison
de
novo
assembl
analysi
fastq
set
sampl
gave
fulllength
hcv
genom
sequenc
singl
contig
sampl
partiallyoverlap
contig
obtain
cover
hcv
sequenc
addit
four
sampl
singl
contig
obtain
determin
blast
subsequ
hmmer
analysi
compris
hpgv
genom
hcv
hpgv
full
genom
sequenc
combin
singl
file
carri
refer
map
nucleotid
frequenc
determin
four
sampl
fastq
set
tabl
sampl
hcv
read
percentag
rang
gave
complet
genom
median
depth
greater
sampl
lowest
viral
load
iuml
read
map
hcv
give
genom
coverag
minimum
depth
depth
median
depth
full
coverag
hpgv
genom
obtain
sampl
median
depth
read
percentag
rang
depth
plot
fig
show
unbias
even
coverag
across
genom
percentag
read
map
viral
target
much
higher
rrnadeplet
sampl
untreat
compar
hcv
hpgv
respect
analysi
hcv
sequenc
show
belong
new
subtyp
within
genotyp
detail
present
separ
manuscript
prepar
hpgv
cluster
genotyp
strain
distinct
nhp
strain
librari
bbv
panel
extract
includ
nhp
neg
control
subject
virusspecif
qpcr
detect
quantif
hcv
hiv
hev
detect
sampl
librari
undetect
riboerasetr
neg
control
librari
supplementari
tabl
sampl
map
refer
sequenc
includ
human
genom
human
rrna
sequenc
evalu
effici
riboeras
treatment
averag
ratio
percentag
read
map
rrna
untreat
versu
treat
sampl
approxim
halv
number
read
map
human
genom
across
panel
fig
except
expect
human
pegiviru
map
neg
control
fastq
set
refer
sequenc
four
bbv
panel
virus
two
pegivirus
vmr
panel
patient
hcv
gave
low
number
read
map
viral
genom
consensu
sequenc
could
deriv
data
section
found
supplementari
tabl
light
larg
everincreas
number
human
rna
viru
pathogen
perhap
unsurpris
standard
serolog
assay
nucleic
acid
test
suffer
lack
sensit
divers
variant
target
virus
overlook
presenc
new
unexpect
virus
provid
limit
inform
target
success
detect
henc
three
main
aim
metagenom
virolog
detect
identifi
known
agent
irrespect
divers
discov
novel
agent
diseas
obtain
complet
sequenc
inform
detect
virus
exist
protocol
achiev
maximum
two
aim
difficulti
select
isol
viral
rna
speci
short
read
sequenc
superabund
host
nucleic
acid
limit
util
metagenom
approach
diagnost
virolog
studi
address
limit
establish
novel
methodolog
suitabl
agnost
detect
character
bloodborn
rna
virus
plasma
sampl
deplet
hostderiv
nucleic
acid
make
modif
exist
librari
prepar
protocol
account
ultralow
rna
input
quantiti
abl
reconstruct
effect
fulllength
genom
hcv
hev
hiv
plasma
sampl
viral
load
iuml
copiesml
hiv
substanti
fraction
complet
genom
iuml
appli
seri
clinic
sampl
could
elucid
simultan
full
genom
sequenc
novel
subtyp
belong
hcv
genotyp
hithertoundetect
human
pegiviru
addit
system
abl
recov
viral
sequenc
panel
divers
rna
virus
dilut
human
plasma
broad
correl
genom
coverag
depth
metric
approxim
concentr
although
full
genom
assembl
mani
case
independ
read
distribut
gave
suffici
genom
coverag
identif
vast
major
rna
molecul
human
plasma
sampl
hostderiv
compris
six
speci
human
rrna
presenc
librari
minimis
two
key
protocol
step
modifi
protocol
firstli
select
extract
method
combin
phenolchloroform
step
column
format
lexogen
split
rna
increas
amount
extract
viral
rna
one
log
compar
extract
method
data
shown
perhap
importantli
control
final
precipit
step
small
rna
molecul
nt
rrna
trna
exclud
eluat
major
molecul
human
genom
dna
secondli
employ
dna
probe
complementari
human
rrna
hybridis
subsequ
digest
rnase
h
dramat
reduc
frequenc
finish
librari
whilst
methodolog
success
use
detect
characteris
two
haemorrhag
fever
virus
frequenc
viral
read
often
addit
hybridcaptur
step
employ
elev
read
method
deplet
rrna
gener
give
poor
recoveri
viral
read
yield
viral
genom
fragment
necessit
low
read
number
even
viral
load
best
requir
dilut
host
viru
pb
order
recov
full
hiv
genom
low
copi
result
rrnadeplet
sampl
extract
typic
contain
quantiti
nucleic
acid
low
picogram
rang
librari
prepar
hexamermedi
revers
transcript
follow
multipl
displac
amplif
constitut
easi
effect
mean
amplifi
low
amount
sever
studi
author
laboratori
signific
amplif
bias
observ
lead
gap
target
genom
consequ
adopt
approach
use
standard
rna
librari
prepar
kit
substanti
modif
compens
minimum
rna
input
requir
least
ng
optim
made
key
chang
rna
fragment
adaptorlig
step
nebnext
ultra
direct
rna
librari
prep
kit
protocol
prior
rna
fragment
heat
dival
cation
improv
sequenc
coverag
overfragment
target
genom
lead
loss
materi
librari
prepar
lower
amount
rna
thu
requir
shorter
optimum
fragment
time
found
minut
optim
term
breadth
genom
coverag
standard
kit
condit
ultralow
rna
input
dramat
skew
ratio
cdna
adaptor
result
adaptor
excess
led
preferenti
amplif
adaptor
dimer
pcr
step
despit
increas
cycl
number
amplifi
low
rna
input
gener
unabl
gener
suffici
quantiti
targetspecif
materi
accur
quantif
consequ
equimolar
pool
librari
compromis
miseq
cluster
effici
found
reduc
final
adaptor
concentr
nm
crucial
reduc
amount
adaptor
dimer
librari
rrnadeplet
sampl
whilst
simultan
extend
pcr
cycl
number
present
studi
serial
dilut
blood
born
viru
panel
prepar
neg
human
plasma
reduc
absolut
quantiti
rel
frequenc
viral
rna
target
maintain
complex
sampl
term
host
nucleic
acid
thu
mimick
clinic
sampl
rrna
deplet
number
divers
viral
read
consist
high
read
map
constitu
viru
genom
throughout
three
sampl
seri
obtain
rel
high
genom
coverag
lowfrequ
viral
target
coinfect
multipl
bloodborn
virus
whilst
specul
depth
coverag
target
virus
would
greater
yet
sampl
confound
effect
unexpect
human
pegivirus
plasma
diluent
patient
sampl
seri
reassur
see
method
perform
well
condit
experi
use
neg
human
plasma
sampl
diluent
abl
recov
level
viral
genom
compar
previou
work
use
pb
bbv
panel
vmr
abl
recov
patient
sampl
larg
percentag
genom
previous
uncharacteris
subtyp
hcv
genotyp
present
iuml
diagnosi
possibl
use
exist
genotyp
assay
presenc
undiagnos
pegiviru
sampl
demonstr
util
method
metagenom
analysi
bloodborn
viru
coinfect
rel
abund
viru
highli
furthermor
three
four
sampl
depth
greater
routin
obtain
like
suffici
call
minor
variant
clinic
full
descript
patient
seri
new
hcv
strain
provid
separ
manuscript
prepar
approach
therefor
accur
characteris
rare
novel
variant
exist
virus
also
gener
level
inform
regard
unexpect
virus
present
sampl
comparison
random
amplificationng
detect
novel
virus
divers
clinic
sampl
requir
techniqu
achiev
full
genom
sequenc
togeth
vmr
panel
result
abl
recov
identifi
sequenc
envelop
virus
hcv
hiv
hev
influenza
sever
paramyxovirus
nonenvelop
virus
sever
enterovirus
astroviru
rotaviru
sapoviru
major
virus
vmr
panel
whilst
dilut
plasma
reduc
total
percentag
read
recov
compar
panel
dilut
pb
greater
breadth
genom
coverag
achiev
absenc
host
nucleic
acid
background
possibl
pb
extract
ultralow
quantiti
rna
despit
adjust
made
librari
prepar
protocol
rna
overfrag
lead
smaller
number
genom
fragment
individu
amplifi
greater
extent
larger
array
fragment
surviv
plasma
extract
develop
similar
approach
kohl
et
al
abl
recov
percentag
read
exceed
viral
load
copiesml
influenza
viru
concentr
copiesml
drop
reoviru
concentr
copiesml
viral
read
method
whole
genom
obtain
highest
viral
load
minor
viral
target
correl
ostens
quantiti
coverag
includ
two
virus
undetect
panel
result
superior
recent
obtain
influenza
clinic
respiratori
presenc
high
quantiti
one
target
like
inhibit
represent
minor
speci
test
individu
superior
depth
coverag
would
seem
like
reduct
fragment
time
even
abolit
may
possibl
use
method
reconstruct
genom
old
partial
degrad
sampl
recent
use
reevalu
earli
hiv
epidem
neg
control
data
suggest
level
contamin
low
viral
read
therein
belong
abund
vmr
panel
member
nelson
et
identifi
second
sourc
contamin
consist
incorrect
read
librari
sequenc
sequenc
run
due
truseq
index
misassign
read
although
crosscontamin
sampl
librari
prepar
anoth
sourc
contamin
qpcr
result
suggest
bbv
panel
genom
present
librari
prepar
neg
control
sampl
conclud
appli
three
adapt
select
larg
rna
extract
rrna
depletiondnas
treatment
extens
modifi
librari
prepar
combin
ng
data
set
produc
plasma
sampl
rich
rna
viru
sequenc
data
complex
bioinformat
process
employ
identifi
virus
within
metagenom
simpl
bioinformat
process
need
detect
identif
known
virus
appli
moder
advanc
tool
agnost
approach
viru
detect
taken
togeth
characteris
full
genom
even
low
viral
load
